StockData
Supernus, Inc. logo

Supernus, Inc. (SUPN) stock

SUPNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 6/30
$39.84+1.96 (+5.17%)

Close on Oct 19, 2026Market cap $4.86BP/E 11.2Yield –

Supernus gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Supernus's gross profit for the twelve months ending Sep 30, 2026 was $1.17B, up 22.8% year over year. For fiscal 2025 it was $994.00M, up 3.9% from the year before. The highest annual figure on record is $994.00M in fiscal 2025.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$994.00M+3.9%
FY2024Dec 31, 2024$957.00M+4.1%
FY2023Dec 31, 2023$919.00M+22.7%
FY2022Dec 31, 2022$749.00M+12.8%
FY2021Dec 31, 2021$664.00M–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$305.00M+32.6%
Q2 FY2026Jun 30, 2026$294.00M+17.6%
Q1 FY2026Mar 31, 2026$277.00M+25.3%
Q4 FY2025Dec 31, 2025$292.00M+16.8%
Q3 FY2025Sep 30, 2025$230.00M-4.6%
Q2 FY2025Jun 30, 2025$250.00M+13.6%
Q1 FY2025Mar 31, 2025$221.00M-10.2%
Q4 FY2024Dec 31, 2024$250.00M–
Q3 FY2024Sep 30, 2024$241.00M–
Q2 FY2024Jun 30, 2024$220.00M–
Q1 FY2024Mar 31, 2024$246.00M–

More Supernus figures

See a number that looks wrong?